Arsenic Trioxide Suppresses Growth of BCR-ABL1 Positive Cells with "Gatekeeper" or Compound Mutation

被引：0
|
作者：
Mian, Afsar Ali [1 ]
Raees, Hadiqa [1 ]
Ahmad, Sujjawal [1 ]
Ottmann, Oliver [2 ]
Lalani, El-Nasir M. A. [1 ]
机构：
[1] Aga Khan Univ, Ctr Regenerat Med & Stem Cell Res, Karachi, Pakistan
[2] Cardiff Univ, Sch Med, Div Canc & Genet, Dept Haematol, Cardiff, Wales
来源：
BLOOD | 2021年 / 138卷
关键词：
D O I：
10.1182/blood-2021-154511
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
4346
引用
收藏
页数：3
相关论文
共 50 条
  • [1] BCR-ABL1 mutation ≠ ponatinib resistance
    Saglio, Giuseppe
    Fava, Carmen
    BLOOD, 2016, 127 (06) : 666 - +
  • [2] A rare case of BCR-ABL1 positive AML - Driver mutation as a bystander
    Liss, B.
    Schostok, S.
    Raghavachar, A.
    ONCOLOGY RESEARCH AND TREATMENT, 2019, 42 : 263 - 264
  • [3] PARP Inhibition Sensitize BCR-ABL1 Positive Cel
    Hiroki, Haruka
    Takagi, Masatoshi
    Ishi, Yuko
    Piao, Jinhua
    Morio, Tomohiro
    BLOOD, 2019, 134
  • [4] PARP Inhibition Sensitize BCR-ABL1 Positive Cell
    Hiroki, Haruka
    Ishii, Yuko
    Piao, Jinhua
    Morio, Tomohiro
    Takagi, Masatoshi
    PEDIATRIC BLOOD & CANCER, 2019, 66 : S12 - S12
  • [5] A CALR Mutation Preceding BCR-ABL1 in an Atypical Myeloproliferative Neoplasm
    Cabagnols, Xenia
    Cayuela, Jean-Michel
    Vainchenker, William
    NEW ENGLAND JOURNAL OF MEDICINE, 2015, 372 (07): : 688 - 690
  • [6] The rise and fall of gatekeeper mutations? The BCR-ABL1 T315I paradigm
    Gibbons, Don L.
    Pricl, Sabrina
    Kantarjian, Hagop
    Cortes, Jorge
    Quintas-Cardama, Alfonso
    CANCER, 2012, 118 (02) : 293 - 299
  • [7] BCR-ABL1 positive lymphoblastic lymphoma - should it be treated like a B-lymphoblastic leukemia with t(9;22);BCR-ABL1?
    Takahashi, Taro
    Ichikawa, Satoshi
    Ichinohasama, Ryo
    Harigae, Hideo
    LEUKEMIA & LYMPHOMA, 2020, 61 (05) : 1265 - 1267
  • [8] PonatinibDrug resistance by compound BCR-ABL1 kinase mutation and BCL2 overexpression: case report
    Reactions Weekly, 2016, 1583 (1) : 889 - 889
  • [9] BCR-ABL1-induced leukemogenesis and autophagic targeting by arsenic trioxide
    Goussetis, Dennis J.
    Gounaris, Elias
    Platanias, Leonidas C.
    AUTOPHAGY, 2013, 9 (01) : 93 - 94
  • [10] Synergistic antiproliferative effect of combined arsenic trioxide-cisplatin treatment in Bcr-Abl positive leukemic cells
    Ota, Akinobu
    Wahiduzzaman, Md
    Karnan, Sivasundaram
    Hyodo, Toshinori
    Konishi, Hiroyuki
    Tsuzuki, Shinobu
    Hosokawa, Yoshitaka
    CANCER SCIENCE, 2018, 109 : 685 - 685
12345